Multimodal Approach to the Intrathecal Catheter for Obstetric Accidental Dural Puncture

NCT05910086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2023-06-18

No results posted yet for this study

Summary

Accidental dural puncture is an uncommon complication of epidural analgesia and can cause postdural puncture headache.

Conditions

  • Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

Interventions

OTHER

collection of data from the medical record

collection of data from the medical record: 1. During epidural space puncture = cerebrospinal fluid (CSF) reflux, presence of glucose / strip, saline injection, intrathecal catheter insertion, intrathecal levobupivacaine and sufentanil injection, catheter insertion time, number of punctures, function of the person performing the procedure. 2. Analgesia and hemodynamics during labor, blood pressure, pulse rate, amount of local anesthetic used, whether emergency cesarean section was performed 3. Demographic data (age, weight, height, body mass index (BMI)) 4. Post-partum monitoring of decubitus or orthostatic headaches, intensity, any other associated clinical signs 5. Analgesics used and their efficacy 6. The use of one or more blood patches, with the volume injected and their efficacy 7. Identification of the breach during epidural analgesia or after delivery 8. Call the patient at 1 week to reassess the episode and its consequences.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Pascal MARTIN, MD · CHU SAINT-ETIENNE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-02-01
Completion
2023-02-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05910086 on ClinicalTrials.gov